Recursion Pharmaceuticals (RXRX) Assets (2020 - 2026)
Recursion Pharmaceuticals (RXRX) reported Assets of $1.21 billion for Q2 2026, down 6.9% from $1.3 billion a year earlier and down 9.5% from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Recursion Pharmaceuticals posted Assets of $1.47 billion, up 1.8% from FY2024.
- Assets has a five-year compound annual growth rate of 37.6% (FY2020 to FY2025).
- By year, Assets came in at $1.45 billion in FY2024 (+121.6%), $653.7 million in FY2023 (-6.8%), $701.29 million in FY2022 (+14.9%) and $610.35 million in FY2021 (+104.4%).
- The Q2 2026 figure ranks as the lowest quarterly Assets since Q3 2024.
- Year over year, Assets gained in seven of the last eight quarters, with growth averaging 53.6%.
- The high point for year-over-year Assets in five years was Q1 2022 (growth of 170.0%); the low point was Q1 2023 (a decline of 14.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.34 billion (Q1 2026), $1.47 billion (Q4 2025) and $1.4 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Recursion Pharmaceuticals | 1.98 Bn | -627.04 Mn | -3.82 Mn | 1.21 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.21 Bn |
| Mar 31, 2026 | 1.34 Bn |
| Dec 31, 2025 | 1.47 Bn |
| Sep 30, 2025 | 1.40 Bn |
| Jun 30, 2025 | 1.30 Bn |
| Mar 31, 2025 | 1.31 Bn |
| Dec 31, 2024 | 1.45 Bn |
| Sep 30, 2024 | 726.50 Mn |
| Jun 30, 2024 | 775.86 Mn |
| Mar 31, 2024 | 557.85 Mn |
| Dec 31, 2023 | 653.70 Mn |
| Sep 30, 2023 | 630.83 Mn |
| Jun 30, 2023 | 666.70 Mn |
| Mar 31, 2023 | 627.37 Mn |
| Dec 31, 2022 | 701.29 Mn |
| Sep 30, 2022 | 611.53 Mn |
| Jun 30, 2022 | 672.52 Mn |
| Mar 31, 2022 | 734.32 Mn |
| Dec 31, 2021 | 610.35 Mn |
| Sep 30, 2021 | 658.61 Mn |
API Access
Recursion Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();